39 results
DEF 14C
OCEL
Organicell Regenerative Medicine, Inc.
20 Dec 23
Information statement
6:30am
this Information Statement to stockholders of Organicell Regenerative Medicine, Inc. (“we,” “us.” “our” or the “Company”) in full satisfaction of any notice
PRE 14C
OCEL
Organicell Regenerative Medicine, Inc.
11 Dec 23
Preliminary information
5:22pm
this Information Statement to stockholders of Organicell Regenerative Medicine, Inc. (“we,” “us.” “our” or the “Company”) in full satisfaction of any notice
PRE 14C
OCEL
Organicell Regenerative Medicine, Inc.
28 Sep 23
Preliminary information
2:54pm
this Information Statement to stockholders of Organicell Regenerative Medicine, Inc. (“we,” “us,” “our,” or the “Company”) in full satisfaction of any
DEF 14C
0b2j2h
14 Aug 23
Information statement
4:34pm
PRE 14C
yy7r71f2kgs ryi
1 Aug 23
Preliminary information
4:15pm
8-K
gnovwh7k
21 Apr 23
Changes in Registrant's Certifying Accountant
4:05pm
8-K
EX-10.1
kx59b q65
6 Sep 22
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-99.1
z3vwhz
20 Jul 22
Organicell Regenerative Medicine, Inc. Secures $4 Million In Funding for Clinical Trials and Agrees to Restructure Management
10:19am
8-K
e1fbbg4meetsor mbf
19 Jul 22
Entry into a Material Definitive Agreement
4:41pm
S-8
EX-99.1
l39ftoyj my
1 Nov 21
Registration of securities for employees
12:00am
DEF 14C
rtiavs9y8hpyklu
5 Oct 21
Information statement
6:00am
PRER14C
nfzymav8w9mvz7r9h
4 Oct 21
Preliminary revised information
6:02am
PRER14C
uptfomp
30 Sep 21
Preliminary revised information
6:01am
PRE 14C
ko1tyhp166
24 Sep 21
Preliminary information
5:25pm